Home
>
National Drug Code (NDC)
>
Mozobil
Mozobil - 58468-0140-1 - (PLERIXAFOR)
Drug Information of Mozobil
| Product NDC: | 58468-0140 |
| Proprietary Name: | Mozobil |
| Non Proprietary Name: | PLERIXAFOR |
| Active Ingredient(s): | 24 mg/1.2mL & nbsp; PLERIXAFOR |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mozobil
| Product NDC: | 58468-0140 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022311 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081215 |
Package Information of Mozobil
| Package NDC: | 58468-0140-1 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (58468-0140-1) > 1.2 mL in 1 VIAL, SINGLE-USE |
NDC Information of Mozobil
| NDC Code | 58468-0140-1 |
| Proprietary Name | Mozobil |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (58468-0140-1) > 1.2 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 58468-0140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PLERIXAFOR |
| Dosage Form Name | SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20081215 |
| Marketing Category Name | NDA |
| Labeler Name | Genzyme Corporation |
| Substance Name | PLERIXAFOR |
| Strength Number | 24 |
| Strength Unit | mg/1.2mL |
| Pharmaceutical Classes | Hematopoietic Stem Cell Mobilizer [EPC],Increased Hematopoietic Stem Cell Mobilization [PE] |
